TransMedics (TMDX) Debt to Equity (2018 - 2025)
Historic Debt to Equity for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $0.17.
- TransMedics' Debt to Equity fell 4059.29% to $0.17 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.17, marking a year-over-year decrease of 4059.29%. This contributed to the annual value of $0.26 for FY2024, which is 3966.94% down from last year.
- TransMedics' Debt to Equity amounted to $0.17 in Q3 2025, which was down 4059.29% from $0.19 recorded in Q2 2025.
- TransMedics' Debt to Equity's 5-year high stood at $0.7 during Q2 2022, with a 5-year trough of $0.17 in Q3 2025.
- For the 5-year period, TransMedics' Debt to Equity averaged around $0.37, with its median value being $0.36 (2021).
- In the last 5 years, TransMedics' Debt to Equity crashed by 5148.33% in 2021 and then soared by 7765.15% in 2022.
- Over the past 5 years, TransMedics' Debt to Equity (Quarter) stood at $0.52 in 2021, then plummeted by 39.61% to $0.31 in 2022, then surged by 37.42% to $0.43 in 2023, then plummeted by 39.67% to $0.26 in 2024, then plummeted by 35.39% to $0.17 in 2025.
- Its Debt to Equity was $0.17 in Q3 2025, compared to $0.19 in Q2 2025 and $0.22 in Q1 2025.